Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
US11786519B2 · kind B2 · utility
0Cited by
15References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 16, 2020 |
| Grant date | Oct 17, 2023 |
| Priority date | — |
| Expiry date | Sep 16, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-xL protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.